Dynamics of Influenza Virus and Human Host Interactions During Infection and Replication Cycle

Bulletin of Mathematical Biology

Volumn 75, Issue 6, 2013, Pages 988-1011

  Madrahimov, Alex ^a   Helikar, Tomáš ^a   Kowal, Bryan ^a   Lu, Guoqing ^a   Rogers, Jim ^a,b  

^a UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Computational modeling; Dynamical model; Influenza A; Probabilistic Boolean network; Systems biology

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C;

ARTICLE; BIOLOGICAL MODEL; COMPUTER SIMULATION; DRUG ANTAGONISM; DRUG EFFECT; HOST PATHOGEN INTERACTION; HUMAN; INFLUENZA; INFLUENZA VIRUS A; MATHEMATICAL PHENOMENA; METABOLISM; PATHOGENICITY; PHYSIOLOGY; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY; VIROLOGY; VIRUS REPLICATION;

COMPUTER SIMULATION; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; MAP KINASE SIGNALING SYSTEM; MATHEMATICAL CONCEPTS; MODELS, BIOLOGICAL; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN KINASE C; SYSTEMS BIOLOGY; VIRUS REPLICATION;

ORTHOMYXOVIRIDAE;

EID: 84879151909     PISSN: 00928240     EISSN: 15229602     Source Type: Journal    
DOI: 10.1007/s11538-012-9777-2     Document Type: Article

References (82)

1. Abdi, A., Tahoori, M. B., & Emamian, E. S. (2008). Fault diagnosis engineering of digital circuits can identify vulnerable molecules in complex cellular pathways. Sci. Signal., 1(42), ra10.
2. Alon, U. (2007). Network motifs: theory and experimental approaches. Nat. Rev. Genet., 8(6), 450-461.
3. Bagowski, C. P., & Ferrell, J. E. (2001). Bistability in the JNK cascade. Curr. Biol., CB, 11(15), 1176-1182.
4. Bagowski, C. P., Besser, J., Frey, C. R., & Ferrell, J. E. (2003). The JNK cascade as a biochemical switch in mammalian cells: ultrasensitive and all-or-none responses. Curr. Biol., CB, 13(4), 315-320.
5. Beauchemin, C., Samuel, J., & Tuszynski, J. (2005). A simple cellular automaton model for influenza A viral infections. J. Theor. Biol., 232(2), 223-234.
6. Beyer, T., Busse, M., Hristov, K., Gurbiel, S., Smida, M., Haus, U.-U., Ballerstein, K., Pfeuffer, F., Weismantel, R., Schraven, B., & Lindquist, J. A. (2011). Integrating signals from the T-cell receptor and the interleukin-2 receptor. PLoS Comput. Biol., 7(8), e1002121.
7. Biswas, S. K., & Nayak, D. P. (1996). Influenza virus polymerase basic protein 1 interacts with influenza virus polymerase basic protein 2 at multiple sites. J. Virol., 70(10), 6716-6722.
8. Boivin, S., Cusack, S., Ruigrok, R. W. H., & Hart, D. J. (2010). Influenza A virus polymerase: structural insights into replication and host adaptation mechanisms. J. Biol. Chem., 285(37), 28411-28417.
9. Boulo, S., Akarsu, H., Ruigrok, R. W. H., & Baudin, F. (2007). Nuclear traffic of influenza virus proteins and ribonucleoprotein complexes. Virus Res., 124(1-2), 12-21.
10. Boyer, L. A., Lee, T. I., Cole, M. F., Johnstone, S. E., Levine, S. S., Zucker, J. P., Guenther, M. G., Kumar, R. M., Murray, H. L., Jenner, R. G., Gifford, D. K., Melton, D. A., Jaenisch, R., & Young, R. A. (2005). Core transcriptional regulatory circuitry in human embryonic stem cells. Cell, 122(6), 947-956.
11. Brandman, O., & Meyer, T. (2008). Feedback loops shape cellular signals in space and time. Science (New York, NY), 322(5900), 390-395.
12. Broadbent, A. J., & Subbarao, K. (2011). Influenza virus vaccines: lessons from the 2009 H1N1 pandemic. Curr. Opin. Virol., 1(4), 254-262.
13. Chaves, M., Albert, R., & Sontag, E. D. (2005). Robustness and fragility of Boolean models for genetic regulatory networks. J. Theor. Biol., 235(3), 431-449.
14. Chaves, M., Sontag, E. D., & Albert, R. (2006). Methods of robustness analysis for Boolean models of gene control networks. Syst. Biol., 153(4), 154-167.
15. Cheng, D., & Qi, H. (2010). State-space analysis of Boolean networks. IEEE Trans. Neural Netw., 21(4), 584-594. A publication of the IEEE Neural Networks Council.
16. Daum, G., Eisenmann-Tappe, I., Fries, H. W., Troppmair, J., & Rapp, U. R. (1994). The ins and outs of Raf kinases. Trends Biochem. Sci., 19(11), 474-480.
17. De Clercq, E. (2006). Antiviral agents active against influenza A viruses. Nat. Rev. Drug Discov., 5(12), 1015-1025.
18. Detjen, B. M., St Angelo, C., Katze, M. G., & Krug, R. M. (1987). The three influenza virus polymerase (P) proteins not associated with viral nucleocapsids in the infected cell are in the form of a complex. J. Virol., 61(1), 16-22.
19. Ehrhardt, C., Marjuki, H., Wolff, T., Nürnberg, B., Planz, O., Pleschka, S., & Ludwig, S. (2006). Bivalent role of the phosphatidylinositol-3-kinase (PI3K) during influenza virus infection and host cell defence. Cell. Microbiol., 8(8), 1336-1348.
20. Ehrhardt, C., Wolff, T., Pleschka, S., Planz, O., Beermann, W., Bode, J. G., Schmolke, M., & Ludwig, S. (2007). Influenza A virus NS1 protein activates the PI3K/Akt pathway to mediate antiapoptotic signaling responses. J. Virol., 81(7), 3058-3067.
21. Eierhoff, T., Hrincius, E. R., Rescher, U., Ludwig, S., & Ehrhardt, C. (2010). The epidermal growth factor receptor (EGFR) promotes uptake of influenza A viruses (IAV) into host cells. PLoS Pathog., 6(9), e1001099.
22. Emmert-Streib, F., & Dehmer, M. (2009). Information processing in the transcriptional regulatory network of yeast: functional robustness. BMC Syst. Biol., 3(35).
23. Engelhardt, O. G., & Fodor, E. (2006). Functional association between viral and cellular transcription during influenza virus infection. Reviews in medical virology, 16(5), 329-345.
24. Ferrell, J. E. (2011). Simple rules for complex processes: new lessons from the budding yeast cell cycle. Mol. Cell, 43(4), 497-500.
25. Forst, C. V. (2006). Host-pathogen systems biology. Drug Discov. Today, 11(5-6), 220-227.
26. Fry, A. M., & Gubareva, L. V. (2012). Understanding influenza virus resistance to antiviral agents; early warning signs for wider community circulation. J. Inf. Dis.
27. Ghanem, A., Mayer, D., Chase, G., Tegge, W., Frank, R., Kochs, G., García-Sastre, A., & Schwemmle, M. (2007). Peptide-mediated interference with influenza A virus polymerase. J. Virol., 81(14), 7801-7804.
28. Gillis, J. S. (2006). An avian influenza vaccine for humans targeting the polymerase B2 protein inside the capsid instead of hemagglutinin or neuramidase on the virus surface. Med. Hypotheses, 66(5), 975-977.
29. Gong, J., Xu, W., & Zhang, J. (2007). Structure and functions of influenza virus neuraminidase. Curr. Med. Chem., 14(1), 113-122.
30. González, S., Zürcher, T., & Ortín, J. (1996). Identification of two separate domains in the influenza virus PB1 protein involved in the interaction with the PB2 and PA subunits: a model for the viral RNA polymerase structure. Nucleic Acids Res., 24(22), 4456-4463.
31. Gubareva, L. V., Kaiser, L., & Hayden, F. G. (2000). Influenza virus neuraminidase inhibitors. Lancet, 355(9206), 827-835.
32. Hancioglu, B., Swigon, D., & Clermont, G. (2007). A dynamical model of human immune response to influenza A virus infection. J. Theor. Biol., 246(1), 70-86.
33. Helikar, T., & Rogers, J. A. (2009). ChemChains: a platform for simulation and analysis of biochemical networks aimed to laboratory scientists. BMC Syst. Biol., 3, 58.
34. Helikar, T., Konvalina, J., Heidel, J., & Rogers, J. A. (2008). Emergent decision-making in biological signal transduction networks. Proc. Natl. Acad. Sci. USA, 105(6), 1913-1918.
35. Helikar, T. T., Kochi, N., Konvalina, J., & Rogers, J. A. (2011). Boolean modeling of biochemical networks. Open Bioinforma. J., 4(5), 16-25.
36. Helikar, T., Kowal, B., McClenathan, S., Bruckner, M., Rowley, T., Madrahimov, A., Wicks, B., Shrestha, M., Limbu, K., & Rogers, J. A. (2012a). The cell collective: toward an open and collaborative approach to systems biology. BMC Syst. Biol., 6(1), 96.
37. Helikar, T., Kowal, B., Madrahimov, A., Shrestha, M., Pedersen, J., Konvalina, J., & Rogers, J. A. (2012b). Bio-Logic Builder: a non-technical tool for building dynamical, qualitative models. PLoS ONE, 7(10), e46417.
38. Herz, C., Stavnezer, E., Krug, R., & Gurney, T. (1981). Influenza virus, an RNA virus, synthesizes its messenger RNA in the nucleus of infected cells. Cell, 26(3 Pt 1), 391-400.
39. Ison, M. G. (2011). Antivirals and resistance: influenza virus. Curr. Opin. Virol., 1(6), 563-573.
40. Kitano, H. (2002). Systems biology: a brief overview. Science, 295(5560), 1662-1664.
41. König, R., Stertz, S., Zhou, Y., Inoue, A., Hoffmann, H.-H., Bhattacharyya, S., Alamares, J. G., Tscherne, D. M., Ortigoza, M. B., Liang, Y., Gao, Q., Andrews, S. E., Bandyopadhyay, S., De Jesus, P., Tu, B. P., Pache, L., Shih, C., Orth, A., Bonamy, G., Miraglia, L., Ideker, T., García-Sastre, A., Young, J. A. T., Palese, P., Shaw, M. L., & Chanda, S. K. (2010). Human host factors required for influenza virus replication. Nature, 463(7282), 813-817.
42. Krumbholz, A., Philipps, A., Oehring, H., Schwarzer, K., Eitner, A., Wutzler, P., & Zell, R. (2011). Current knowledge on PB1-F2 of influenza A viruses. Med. Microbiol. Immunol., 200(2), 69-75.
43. Lee, T. I., Rinaldi, N. J., Robert, F., Odom, D. T., Bar-Joseph, Z., Gerber, G. K., Hannett, N. M., Harbison, C. T., Thompson, C. M., Simon, I., Zeitlinger, J., Jennings, E. G., Murray, H. L., Gordon, D. B., Ren, B., Wyrick, J. J., Tagne, J.-B., Volkert, T. L., Fraenkel, E., Gifford, D. K., & Young, R. A. (2002). Transcriptional regulatory networks in saccharomyces cerevisiae. Science (New York, NY), 298(5594), 799-804.
44. Ludwig, S., Pleschka, S., Planz, O., & Wolff, T. (2006). Ringing the alarm bells: signalling and apoptosis in influenza virus infected cells. Cell. Microbiol., 8(3), 375-386.
45. Ma'ayan, A., Jenkins, S. L., Neves, S., Hasseldine, A., Grace, E., Dubin-Thaler, B., Eungdamrong, N. J., Weng, G., Ram, P. T., Rice, J. J., Kershenbaum, A., Stolovitzky, G. A., Blitzer, R. D., & Iyengar, R. (2005). Formation of regulatory patterns during signal propagation in a Mammalian cellular network. Science (New York, NY), 309(5737), 1078-1083.
46. Mangan, S., & Alon, U. (2003). Structure and function of the feed-forward loop network motif. Proc. Natl. Acad. Sci. USA, 100(21), 11980-11985.
47. Mangan, S., Zaslaver, A., & Alon, U. (2003). The coherent feedforward loop serves as a sign-sensitive delay element in transcription networks. J. Mol. Biol., 334(2), 197-204.
48. Matallanas, D., Birtwistle, M., Romano, D., Zebisch, A., Rauch, J., von Kriegsheim, A., & Kolch, W. (2011). Raf family kinases: old dogs have learned new tricks. Genes Cancer, 2(3), 232-260.
49. Milo, R., Shen-Orr, S., Itzkovitz, S., Kashtan, N., Chklovskii, D., & Alon, U. (2002). Network motifs: simple building blocks of complex networks. Science (New York, NY), 298(5594), 824-827.
50. Morris, M. K., Saez-Rodriguez, J., Sorger, P. K., & Lauffenburger, D. A. (2010). Logic-based models for the analysis of cell signaling networks. Biochemistry, 49(15), 3216-3224.
51. Nakazawa, M., Kadowaki, S., Watanabe, I., Kadowaki, Y., Takei, M., & Fukuda, H. (2008). PA subunit of RNA polymerase as a promising target for anti-influenza virus agents. Antivir. Res., 78(3), 194-201.
52. Naldi, A., Carneiro, J., Chaouiya, C., & Thieffry, D. (2010). Diversity and plasticity of Th cell types predicted from regulatory network modelling. PLoS Comput. Biol., 6(9), e1000912.
53. Odom, D. T., Zizlsperger, N., Gordon, D. B., Bell, G. W., Rinaldi, N. J., Murray, H. L., Volkert, T. L., Schreiber, J., Rolfe, P. A., Gifford, D. K., Fraenkel, E., Bell, G. I., & Young, R. A. (2004). Control of pancreas and liver gene expression by HNF transcription factors. Science (New York, NY), 303(5662), 1378-1381.
54. Ohtsu, Y., Honda, Y., Sakata, Y., Kato, H., & Toyoda, T. (2002). Fine mapping of the subunit binding sites of influenza virus RNA polymerase. Microbiol. Immunol., 46(3), 167-175.
55. O'Neill, R. E., Talon, J., & Palese, P. (1998). The influenza virus NEP (NS2 protein) mediates the nuclear export of viral ribonucleoproteins. EMBO J., 17(1), 288-296.
56. Oslund, K. L., & Baumgarth, N. (2011). Influenza-induced innate immunity: regulators of viral replication, respiratory tract pathology & adaptive immunity. Future Virol., 6(8), 951-962.
57. Payungporn, S., Panjaworayan, N., Makkoch, J., & Poovorawan, Y. (2010). Molecular characteristics of the human pandemic influenza A virus (H1N1). Acta Virol., 54(3), 155-163.
58. Pérez, D. R., & Donis, R. O. (1995). A 48-amino-acid region of influenza A virus PB1 protein is sufficient for complex formation with PA. J. Virol., 69(11), 6932-6939.
59. Pinto, L. H., Holsinger, L. J., & Lamb, R. A. (1992). Influenza virus M2 protein has ion channel activity. Cell, 69(3), 517-528.
60. Pleschka, S., Wolff, T., Ehrhardt, C., Hobom, G., Planz, O., Rapp, U. R., & Ludwig, S. (2001). Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade. Nat. Cell Biol., 3(3), 301-305.
61. Poole, E. L., Medcalf, L., Elton, D., & Digard, P. (2007). Evidence that the C-terminal PB2-binding region of the influenza A virus PB1 protein is a discrete alpha-helical domain. FEBS Lett., 581(27), 5300-5306.
62. Rodríguez, A., Sosa, D., Torres, L., Molina, B., Frías, S., & Mendoza, L. (2012). A Boolean network model of the FA/BRCA pathway. Bioinformatics (Oxford, England), 28(6), 858-866.
63. Root, C. N., Wills, E. G., McNair, L. L., & Whittaker, G. R. (2000). Entry of influenza viruses into cells is inhibited by a highly specific protein kinase C inhibitor. J. Gen. Virol., 81(Pt 11), 2697-2705.
64. Rossman, J. S., & Lamb, R. A. (2011). Influenza virus assembly and budding. Virology, 411(2), 229-236.
65. Saez-Rodriguez, J., Simeoni, L., Lindquist, J. A., Hemenway, R., Bommhardt, U., Arndt, B., Haus, U.-U., Weismantel, R., Gilles, E. D., Klamt, S., & Schraven, B. (2007). A logical model provides insights into T cell receptor signaling. PLoS Comput. Biol., 3(8), e163.
66. Shapira, S. D., Gat-Viks, I., Shum, B. O. V., Dricot, A., de Grace, M. M., Wu, L., Gupta, P. B., Hao, T., Silver, S. J., Root, D. E., Hill, D. E., Regev, A., & Hacohen, N. (2009). A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell, 139(7), 1255-1267.
67. Shen-Orr, S. S., Milo, R., Mangan, S., & Alon, U. (2002). Network motifs in the transcriptional regulation network of Escherichia coli. Nat. Genet., 31(1), 64-68.
68. Siciliano, V., Menolascina, F., Marucci, L., Fracassi, C., Garzilli, I., Moretti, M. N., & di Bernardo, D. (2011). Construction and modelling of an inducible positive feedback loop stably integrated in a mammalian cell-line. PLoS Comput. Biol., 7(6), e1002074.
69. Sidorenko, Y., & Reichl, U. (2004). Structured model of influenza virus replication in MDCK cells. Biotechnol. Bioeng., 88(1), 1-14.
70. Sieczkarski, S. B., Brown, H. A., & Whittaker, G. R. (2003). Role of protein kinase C betaII in influenza virus entry via late endosomes. J. Virol., 77(1), 460-469.
71. Skehel, J. (2009). An overview of influenza haemagglutinin and neuraminidase. Biol., J. Int. Assoc. Biol. Stand., 37(3), 177-178.
72. Song, B. M., Kang, Y. M., Kim, H. S., & Seo, S. H. (2011). Induction of inflammatory cytokines and toll-like receptors in human normal respiratory epithelial cells infected with seasonal H1N1, 2009 pandemic H1N1, seasonal H3N2, and highly pathogenic H5N1 influenza virus. Viral Immunol., 24(3), 179-187.
73. Takeda, M., Pekosz, A., Shuck, K., Pinto, L. H., & Lamb, R. A. (2002). Influenza a virus M2 ion channel activity is essential for efficient replication in tissue culture. J. Virol., 76(3), 1391-1399.
74. Trautmann, L., & Sekaly, R.-P. (2011). Solving vaccine mysteries: a systems biology perspective. Nat. Immunol., 12(8), 729-731.
75. Turan, K., Mibayashi, M., Sugiyama, K., Saito, S., Numajiri, A., & Nagata, K. (2004). Nuclear MxA proteins form a complex with influenza virus NP and inhibit the transcription of the engineered influenza virus genome. Nucleic Acids Res., 32(2), 643-652.
76. Umezawa, T. (2011). Systems biology approaches to abscisic acid signaling. J. Plant Res., 124(4), 539-548.
77. Watanabe, T., Watanabe, S., & Kawaoka, Y. (2010). Cellular networks involved in the influenza virus life cycle. Cell Host Microbe, 7(6), 427-439.
78. Webster, R. G., Bean, W. J., Gorman, O. T., Chambers, T. M., & Kawaoka, Y. (1992). Evolution and ecology of influenza A viruses. Microbiol. Rev., 56(1), 152-179.
79. Wilkinson, T. M., Li, C. K. F., Chui, C. S. C., Huang, A. K. Y., Perkins, M., Liebner, J. C., Lambkin-Williams, R., Gilbert, A., Oxford, J., Nicholas, B., Staples, K. J., Dong, T., Douek, D. C., McMichael, A. J., & Xu, X.-N. (2012). Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat. Med., 18(2), 274-280.
80. Wunderlich, K., Mayer, D., Ranadheera, C., Holler, A.-S., Mänz, B., Martin, A., Chase, G., Tegge, W., Frank, R., Kessler, U., & Schwemmle, M. (2009). Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. PLoS ONE, 4(10), e7517.
81. Yan, Q. (2010). Systems biology of influenza: understanding multidimensional interactions for personalized prevention and treatment. Methods Mol. Biol., 662, 285-302.
82. Zheng, J., Zhang, D., Przytycki, P. F., Zielinski, R., Capala, J., & Przytycka, T. M. (2010). SimBoolNet-a cytoscape plugin for dynamic simulation of signaling networks. Bioinformatics (Oxford, England), 26(1), 141-142.